FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels
(By Alexandra Murphy for Becker’s Hospital Review) The FDA has updated the labels for all GLP-1 receptor agonists, including popular
Read More
FDA
Why hospitals still can’t get the supplies they need
(By Stefanie Asin for Becker’s Hospital Review) During the COVID-19 pandemic, healthcare supply chain issues were complex and plentiful, creating
Read MoreOptum joins CVS, Cigna in dropping Humira
(By Rylee Wilson for Becker’s Hospital Review) Optum Rx will join the other major pharmacy benefit managers and exclude Humira
Read MoreWith TV Drug Ads, What You See Is Not Necessarily What You Get
(By Elisabeth Rosenthal for KFF Health News) Triumphant music plays as cancer patients go camping, do some gardening, and watch
Read More6 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) The sole suppliers for a few medications, including a Parkinson’s disease therapy, are
Read MoreFAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for The Kaiser Family Foundation Published: Aug 20, 2024) The Inflation Reduction Act of 2022 (the Act),
Read More5 drugs now in shortage
(By Paige Twenter for Becker’s Hospital Review) About two-thirds of providers recently told Premier their teams are spending more than
Read MoreThe FDA Calls Them ‘Recalls,’ Yet the Targeted Medical Devices Often Remain in Use
(By David Hilzenrath for KFF Health News) In 2016, medical device giant Abbott issued a recall for its MitraClip cardiac
Read MoreFDA calls out Bristol Myers over cancer drug claims
(By Elizabeth Gregerson for Becker’s Hospital Review) The FDA has accused pharmaceutical company Bristol Myers Squibb of making false or
Read MoreFDA gives thumbs down to MDMA for now, demanding further research
(By Will Stone for NPR) On Friday, drugmaker Lykos Therapeutics received word from the Food and Drug Administration that the
Read More